Posard Matthew L.
Insider CIK 1543792 · ILMN Sr VP & General Manager · HALO Director · TROV Chief Commercial Officer · TLIS Director · DMTK Director · NAUT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-10-01 | 2026-10-02 | 100 | $110.04 | $11.0K | 53,609 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-10-01 | 2026-10-02 | 1,100 | $109.57 | $120.5K | 53,709 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-10-01 | 2026-10-02 | 3,300 | $108.45 | $357.9K | 54,809 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-10-01 | 2026-10-02 | 730 | $107.17 | $78.2K | 58,109 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-09-16 | 2026-09-17 | 4,000 | $108.99 | $436.0K | 58,839 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-09-16 | 2026-09-17 | 3,100 | $106.13 | $329.0K | 74,735 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-09-16 | 2026-09-17 | 8,896 | $108.04 | $961.1K | 62,839 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-09-16 | 2026-09-17 | 3,000 | $106.83 | $320.5K | 71,735 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-09-16 | 2026-09-17 | 4,000 | $108.99 | $436.0K | 58,839 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-09-16 | 2026-09-17 | 8,896 | $108.04 | $961.1K | 62,839 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-09-16 | 2026-09-17 | 3,000 | $106.83 | $320.5K | 71,735 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2026-09-16 | 2026-09-17 | 3,100 | $106.13 | $329.0K | 74,735 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2026-06-18 | 2026-06-22 | 45,000 | — | $0 | 45,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2026-05-05 | 2026-05-07 | 6,040 | — | $0 | 6,040 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2026-05-05 | 2026-05-07 | 3,796 | — | $0 | 77,835 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2025-06-23 | 2025-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2025-05-01 | 2025-05-02 | 5,750 | — | $0 | 5,750 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2025-05-01 | 2025-05-02 | 4,165 | — | $0 | 74,039 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2024-08-14 | 2024-08-14 | 9,881 | $57.70 | $570.1K | 69,874 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2024-08-13 | 2024-08-14 | 10,000 | $56.19 | $561.9K | 79,755 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2024-08-12 | 2024-08-14 | 10,000 | $55.72 | $557.2K | 89,755 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2024-06-14 | 2024-06-17 | 45,000 | — | $0 | 45,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2024-06-12 | 2024-06-13 | 10,000 | $50.62 | $506.2K | 99,755 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2024-06-11 | 2024-06-13 | 10,000 | $50.01 | $500.1K | 109,755 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2024-04-25 | 2024-04-29 | 8,804 | — | $0 | 8,804 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2024-04-25 | 2024-04-29 | 6,501 | — | $0 | 119,755 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2023-06-15 | 2023-06-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TLIS Talis Biomedical Corp | A Award deriv | 2023-06-09 | 2023-06-12 | 95,000 | — | $0 | 95,000 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2023-06-01 | 2023-06-05 | 35,714 | — | $0 | 158,215 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2023-05-05 | 2023-05-09 | 11,371 | — | $0 | 11,371 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2023-05-05 | 2023-05-09 | 8,065 | — | $0 | 113,254 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2022-12-06 | 2022-12-06 | 10,000 | $56.12 | $561.2K | 105,189 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2022-12-05 | 2022-12-06 | 10,000 | $55.74 | $557.4K | 115,189 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | S Sale | 2022-12-02 | 2022-12-06 | 10,000 | $58.80 | $588.0K | 125,189 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2022-06-15 | 2022-06-16 | 86,467 | — | $0 | 86,467 | SEC↗ |
| TLIS Talis Biomedical Corp | A Award deriv | 2022-06-10 | 2022-06-13 | 95,000 | — | $0 | 95,000 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2022-05-26 | 2022-05-31 | 26,480 | — | $0 | 122,501 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2022-05-05 | 2022-05-06 | 6,206 | — | $0 | 135,189 | SEC↗ |
| NAUT Nautilus Biotechnology, In | P Buy | 2021-12-01 | 2021-12-01 | 10,000 | $4.46 | $44.6K | 40,000 | SEC↗ |
| NAUT Nautilus Biotechnology, In | P Buy | 2021-12-01 | 2021-12-01 | 10,000 | $4.45 | $44.5K | 50,000 | SEC↗ |
| NAUT Nautilus Biotechnology, In | P Buy | 2021-12-01 | 2021-12-01 | 10,000 | $4.50 | $45.0K | 30,000 | SEC↗ |
| NAUT Nautilus Biotechnology, In | P Buy | 2021-11-30 | 2021-12-01 | 20,000 | $4.57 | $91.4K | 20,000 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2021-05-26 | 2021-05-28 | 4,497 | — | $0 | 91,360 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2021-05-26 | 2021-05-28 | 4,661 | — | $0 | 96,021 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2021-05-05 | 2021-05-06 | 5,230 | — | $0 | 128,983 | SEC↗ |
| TLIS Talis Biomedical Corp | P Buy | 2021-02-17 | 2021-02-19 | 62,500 | $16.00 | $1.00M | 62,500 | SEC↗ |
| DMTK DermTech, Inc. | P Buy | 2021-01-11 | 2021-01-13 | 33,898 | $29.50 | $1000.0K | 86,863 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2020-06-17 | 2020-06-19 | 8,000 | — | $0 | 52,965 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2020-04-30 | 2020-05-01 | 8,829 | — | $0 | 123,753 | SEC↗ |
| DMTK DermTech, Inc. | M Exercise deriv | 2020-04-29 | 2020-05-01 | 9,702 | — | $0 | 0 | SEC↗ |
| DMTK DermTech, Inc. | M Exercise | 2020-04-29 | 2020-05-01 | 9,702 | $6.94 | $67.3K | 44,965 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2020-01-30 | 2020-02-03 | 6,000 | — | $0 | 35,263 | SEC↗ |
| DMTK DermTech, Inc. | M Exercise deriv | 2019-12-31 | 2020-01-03 | 15,994 | — | $0 | 0 | SEC↗ |
| DMTK DermTech, Inc. | M Exercise | 2019-12-31 | 2020-01-03 | 15,994 | — | $0 | 29,263 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2019-05-02 | 2019-05-03 | 12,173 | — | $0 | 114,924 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2018-05-02 | 2018-05-02 | 10,363 | — | $0 | 102,751 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2017-05-04 | 2017-05-05 | 14,135 | — | $0 | 92,388 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2016-05-04 | 2016-05-06 | 20,202 | — | $0 | 78,253 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2016-01-04 | 2016-01-06 | 150,000 | — | $0 | 650,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2015-05-06 | 2015-05-07 | 13,175 | — | $0 | 58,051 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2014-05-13 | 2014-05-14 | 24,876 | — | $0 | 44,876 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise deriv | 2013-05-30 | 2013-05-30 | 2,836 | — | $0 | 7,563 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-05-30 | 2013-05-30 | 2,836 | $37.04 | $105.0K | 33,694 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-05-30 | 2013-05-30 | 2,836 | $70.80 | $200.8K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise deriv | 2013-04-11 | 2013-04-15 | 5,032 | — | $0 | 0 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise deriv | 2013-04-11 | 2013-04-15 | 17,850 | — | $0 | 0 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise deriv | 2013-04-11 | 2013-04-15 | 8,334 | — | $0 | 0 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise deriv | 2013-04-11 | 2013-04-15 | 17,016 | — | $0 | 10,399 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-11 | 2013-04-15 | 5,032 | $32.49 | $163.5K | 35,890 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-11 | 2013-04-15 | 2,836 | $57.95 | $164.3K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-11 | 2013-04-15 | 2,836 | $37.04 | $105.0K | 33,694 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-11 | 2013-04-15 | 5,032 | $57.95 | $291.6K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-11 | 2013-04-15 | 8,334 | $20.04 | $167.0K | 39,192 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-11 | 2013-04-15 | 8,334 | $57.95 | $483.0K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-11 | 2013-04-15 | 2,100 | $28.45 | $59.7K | 32,958 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-11 | 2013-04-15 | 3,781 | $37.04 | $140.0K | 34,639 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-11 | 2013-04-15 | 3,781 | $57.95 | $219.1K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-11 | 2013-04-15 | 10,399 | $37.04 | $385.2K | 41,257 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-11 | 2013-04-15 | 10,399 | $57.95 | $602.6K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-11 | 2013-04-15 | 11,550 | $57.95 | $669.3K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-11 | 2013-04-15 | 11,550 | $28.45 | $328.6K | 42,408 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-11 | 2013-04-15 | 4,200 | $57.95 | $243.4K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | M Exercise | 2013-04-11 | 2013-04-15 | 4,200 | $28.45 | $119.5K | 35,058 | SEC↗ |
| ILMN ILLUMINA INC | S Sale | 2013-04-11 | 2013-04-15 | 2,100 | $57.95 | $121.7K | 30,858 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2013-03-27 | 2013-03-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ILMN ILLUMINA INC | F Tax w/h | 2013-03-08 | 2013-03-12 | 685 | $53.77 | $36.8K | 31,797 | SEC↗ |
| ILMN ILLUMINA INC | F Tax w/h | 2013-03-08 | 2013-03-12 | 939 | $53.77 | $50.5K | 30,858 | SEC↗ |
| ILMN ILLUMINA INC | F Tax w/h | 2013-01-31 | 2013-01-31 | 300 | $50.63 | $15.2K | 31,867 | SEC↗ |
| ILMN ILLUMINA INC | A Award deriv | 2013-01-29 | 2013-01-31 | 20,063 | — | $0 | 20,063 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2013-01-29 | 2013-01-31 | 4,458 | — | $0 | 32,167 | SEC↗ |
| ILMN ILLUMINA INC | F Tax w/h | 2013-01-28 | 2013-01-29 | 728 | $51.62 | $37.6K | 27,709 | SEC↗ |
| ILMN ILLUMINA INC | F Tax w/h | 2013-01-27 | 2013-01-29 | 662 | $51.62 | $34.2K | 28,437 | SEC↗ |
| ILMN ILLUMINA INC | A Award deriv | 2012-03-08 | 2012-03-12 | 32,813 | — | $0 | 32,813 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2012-03-08 | 2012-03-12 | 7,292 | — | $0 | 29,099 | SEC↗ |
| ILMN ILLUMINA INC | A Award | 2012-03-08 | 2012-03-12 | 5,000 | — | $0 | 21,807 | SEC↗ |